HXBM

Helix BioMedix, Inc. HXBM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HXBM ORGS BPTH EMMA SQZB CNTRF SYBE PAIOF NSTM NGMC
6M -68.99 % -84.44 % -63.16 % -29.93 % -17.86 % -70.99 % 0.00 % 0.00 % -24.81 % 15.38 %
YTD -75.00 % -86.98 % -93.91 % 23.65 % -23.33 % -77.70 % 0.00 % -50.00 % 129.89 % 76.47 %
1Y -77.78 % -82.97 % -93.69 % -24.66 % -8.00 % -77.70 % 0.00 % -50.00 % 80.59 % 76.47 %
3Y -92.31 % -98.53 % -99.74 % -97.00 % -97.05 % -99.44 % -50.00 % -99.87 % -88.83 % 150.00 %
5Y -91.94 % -99.41 % -99.91 % -98.98 % -99.92 % -99.70 % -50.00 % -99.97 % -85.96 % 114.29 %
10Y -95.74 % -99.31 % -100.00 % -99.95 % -99.83 % -99.71 % -50.00 % -99.95 % -97.01 % 15.38 %
From the beginning -99.56 % -99.84 % -100.00 % -98.25 % -99.83 % -99.71 % -50.00 % -99.96 % -99.76 % -100.00 %

Dividend

NovelStem International Corp.